Advertisement

Advertisement

VANI Stock Latest News

Vivani Medical Highlights Upcoming SLIM-1 First Dosing Milestone

Company AnnouncementsVivani Medical Highlights Upcoming SLIM-1 First Dosing Milestone

Vivani Medical: Buy Rating Reaffirmed as Novo Nordisk Evaluation and Cortigent–ClearOne Merger Support $3.50 Price Target

PremiumRatings

Vivani Medical: Buy Rating Reaffirmed as Novo Nordisk Evaluation and Cortigent–ClearOne Merger Support $3.50 Price Target

22d ago

Vivani Advances GLP-1 Implant Program With Novo Nordisk

PremiumCompany Announcements

Vivani Advances GLP-1 Implant Program With Novo Nordisk

24d ago

Vivani Medical enters pact with Novo Nordisk to evaluate NPM-139

PremiumThe Fly

Vivani Medical enters pact with Novo Nordisk to evaluate NPM-139

24d ago

Vivani Medical to merge Cortigent subsidiary with ClearOne

PremiumThe Fly

Vivani Medical to merge Cortigent subsidiary with ClearOne

29d ago

ClearOne enters into merger agreement with Cortigent

PremiumThe FlyClearOne enters into merger agreement with Cortigent

29d ago

AI Models Turn Cautiously More Constructive on Vivani Medical (VANI)

AI Analyst Ratings

AI Models Turn Cautiously More Constructive on Vivani Medical (VANI)

1M ago

Vivani Medical Advances SLIM-1 Trial for Obesity Treatment

Company Announcements

Vivani Medical Advances SLIM-1 Trial for Obesity Treatment

1M ago

Vivani receives approval from Bellberry to initiate SLIM-1 trial in Australia

PremiumThe Fly

Vivani receives approval from Bellberry to initiate SLIM-1 trial in Australia

1M ago

Vivani Medical initiated with a Buy at Lake Street

PremiumThe Fly

Vivani Medical initiated with a Buy at Lake Street

1M ago

Vivani Medical director buys $2.0M in common stock

PremiumThe Fly

Vivani Medical director buys $2.0M in common stock

2M ago

Vivani Medical Highlights Investor Presentation at Jefferies Conference

PremiumCompany Announcements

Vivani Medical Highlights Investor Presentation at Jefferies Conference

2M ago

Vivani Highlights Q1 Progress on Semaglutide Implant Program

PremiumCompany AnnouncementsVivani Highlights Q1 Progress on Semaglutide Implant Program

3M ago

AI Models See Vivani Medical as a High-Risk Momentum Play After Capital Raise

AI Analyst Ratings

AI Models See Vivani Medical as a High-Risk Momentum Play After Capital Raise

3M ago

Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright

The Fly

Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright

4M ago

Vivani: Solid Funding Runway and Strategic Catalysts Underpin Buy Rating

PremiumRatings

Vivani: Solid Funding Runway and Strategic Catalysts Underpin Buy Rating

4M ago

Vivani Medical, Inc. (VANI) Q4 Earnings Cheat Sheet

PremiumPre-Earnings

Vivani Medical, Inc. (VANI) Q4 Earnings Cheat Sheet

4M ago

Vivani’s Cortigent presents 6-year results for Orion system at NANS 2026

PremiumThe Fly

Vivani’s Cortigent presents 6-year results for Orion system at NANS 2026

6M ago

Vivani Medical Announces Equity Offerings to Fund Pipeline

PremiumCompany Announcements

Vivani Medical Announces Equity Offerings to Fund Pipeline

6M ago

Vivani subsidiary to present poster on Orion Visual Cortical Prosthesis System

PremiumThe FlyVivani subsidiary to present poster on Orion Visual Cortical Prosthesis System

6M ago

Vivani Medical’s NPM-139: A Promising Semaglutide Implant with Strong Buy Rating

Ratings

Vivani Medical’s NPM-139: A Promising Semaglutide Implant with Strong Buy Rating

9M ago

Vivani Medical’s Innovative Semaglutide Implant and Market Positioning Drive Buy Recommendation

Ratings

Vivani Medical’s Innovative Semaglutide Implant and Market Positioning Drive Buy Recommendation

9M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >